Cargando…
Bound to bleed: How altered albumin binding may dictate warfarin treatment outcome
Although non-vitamin-K anticoagulants are now the preferred option for stroke prevention in atrial fibrillation (AF), warfarin is still used in a significant number of patients. Warfarin dosing requirements are susceptible to drug interactions and genetic polymorphisms in metabolising enzymes. Human...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437285/ https://www.ncbi.nlm.nih.gov/pubmed/30963099 http://dx.doi.org/10.1016/j.ijcha.2019.02.007 |